GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,460,000 | +3.8% | 33,097 | -10.0% | 0.10% | -12.7% |
| Q3 2021 | $1,406,000 | -1.7% | 36,782 | +2.4% | 0.11% | -4.3% |
| Q2 2021 | $1,431,000 | +412.9% | 35,916 | +359.6% | 0.12% | +360.0% |
| Q1 2021 | $279,000 | +83.6% | 7,814 | +90.1% | 0.02% | +66.7% |
| Q4 2020 | $152,000 | +0.7% | 4,110 | +2.8% | 0.02% | -6.2% |
| Q3 2020 | $151,000 | -4.4% | 3,998 | -4.1% | 0.02% | -20.0% |
| Q1 2020 | $158,000 | -45.7% | 4,167 | -32.5% | 0.02% | -33.3% |
| Q4 2019 | $291,000 | -13.4% | 6,169 | -21.5% | 0.03% | -16.7% |
| Q3 2019 | $336,000 | +37.1% | 7,856 | +28.4% | 0.04% | +38.5% |
| Q2 2019 | $245,000 | +21.3% | 6,120 | +27.1% | 0.03% | -49.0% |
| Q1 2019 | $202,000 | -16.5% | 4,815 | -24.0% | 0.05% | +2.0% |
| Q4 2018 | $242,000 | -24.6% | 6,334 | -20.8% | 0.05% | -66.4% |
| Q3 2018 | $321,000 | -10.8% | 7,996 | -10.5% | 0.15% | +8.0% |
| Q2 2018 | $360,000 | -13.5% | 8,930 | -16.2% | 0.14% | +56.8% |
| Q1 2018 | $416,000 | +3.7% | 10,654 | +9.0% | 0.09% | -21.4% |
| Q3 2017 | $401,000 | -99.9% | 9,777 | -27.0% | 0.11% | -20.6% |
| Q2 2017 | $578,000,000 | +6.4% | 13,396 | +0.9% | 0.14% | -6.6% |
| Q1 2017 | $543,000,000 | -35.7% | 13,278 | -39.4% | 0.15% | +2.0% |
| Q4 2016 | $844,000,000 | +99663.6% | 21,915 | +11.7% | 0.15% | -3.3% |
| Q3 2016 | $846,000 | +45.6% | 19,617 | +46.3% | 0.15% | -16.8% |
| Q2 2016 | $581,000 | +5.3% | 13,408 | -1.6% | 0.18% | -5.6% |
| Q1 2016 | $552,000 | -6.9% | 13,629 | -7.4% | 0.20% | -11.8% |
| Q4 2015 | $593,000 | -8.1% | 14,717 | -12.3% | 0.22% | -4.3% |
| Q3 2015 | $645,000 | -24.6% | 16,786 | -18.3% | 0.23% | -21.7% |
| Q2 2015 | $855,000 | -28.8% | 20,534 | -21.2% | 0.30% | -23.4% |
| Q1 2015 | $1,201,000 | +12.9% | 26,042 | +4.6% | 0.38% | +8.8% |
| Q4 2014 | $1,064,000 | -33.6% | 24,895 | -28.6% | 0.35% | +11.0% |
| Q3 2014 | $1,603,000 | +199.1% | 34,861 | +203.1% | 0.32% | +13.9% |
| Q2 2014 | $536,000 | – | 11,501 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |